LFCR - Lifecore Biomedical, Inc. Forward P/S Multiple

Lifecore Biomedical (LFCR) cash flows depend on the reliability of external raw material suppliers. The forward P/S dynamics of the company confirm these links, where 1.30 reflects the baseline level of the metric. Internal optimization has ensured working capital stability, while unique expertise in syringe filling has solidified its status as an indispensable partner in the production of innovative injectables for the market's largest players.

Lifecore Biomedical, Inc. - LFCR Future Price to Revenue (period 04/28/2023 - 08/31/2026)

Summary analytical data breakdowns for lifecore.com (LFCR)

- market price and analyst price targets:

Price Chart Lifecore Biomedical, Inc.|LFCR - Price Target Chart

- market capitalization statistics:

Market Capitalization Lifecore Biomedical, Inc.|LFCR - Company Buyout Price

- issuer book value statistics:

Book Value per Share Lifecore Biomedical|LFCR - Net Asset Value|Market Capitalization to Book Value Ratio lifecore.com|LFCR - Company Assets

- company liabilities and liquidity data:

Total Debt to Capital Lifecore Biomedical|LFCR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Lifecore Biomedical, Inc.|LFCR - Company Cumulative Debt|Debt to Book Capitalization Ratio Lifecore Biomedical, Inc.|LFCR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Lifecore Biomedical|Quick Liquidity Indicator lifecore.com

- financial results and valuation multiples details:

LFCR - Final Profit|Projected Future Earnings Lifecore Biomedical|LFCR - Price to Earnings Ratio|Forward P/E Multiple Lifecore Biomedical, Inc.|LFCR - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lifecore Biomedical, Inc.|LFCR - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Lifecore Biomedical|LFCR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth lifecore.com|LFCR - Earnings per share growth rate in current year|Earnings growth forecast for next year Lifecore Biomedical

- sales volume and revenue information:

LFCR - Company Sales Volume|Projected Sales Volume Lifecore Biomedical, Inc.|LFCR - Price-to-Revenue Coefficient|Forward P/S Multiple Lifecore Biomedical, Inc.

Initial company analysis:LFCR (Lifecore)

Product sample of Lifecore Biomedical, Inc.

Lifecore Biomedical (LFCR) is optimizing contract manufacturing transparency to restore market confidence, making the monitoring of revenue generation efficiency critical. The current value of 1.30 reflects the ratio of market capitalization to projected sales, allowing investors to use the forward price-to-sales ratio to assess the risk of asset undervaluation and the business's ability to sustain demand amid macroeconomic volatility.

Key competitors

Price-to-Projected Revenue Ratio IQVIA IQV|Labcorp Holdings - Price-to-Projected Revenue Ratio|Medpace Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio ICON Public ICLR|CRL: Forward P/S Multiple|Future Price to Revenue EVO (evotec.com)|FTRE (Fortrea) - Forward P/S Multiple|Market Cap to Future Revenue Ratio OmniAb Inc. OABI|Forward P/S Multiple NOTV|Forward Price-to-Revenue Multiple Avid Bioservices Inc CDMO|Price-to-Projected Revenue Ratio Catalent, Inc. CTLT|nighthawkbio.com (SCPX) - Market Cap to Future Revenue Ratio